Defining candidate drug characteristics for Long-QT (LQT3) syndrome
-
1.
Center for Biomedical Computing, Simula Research Laboratory, P.O. Box 134, Lysaker 1325
-
2.
Cardiac Bioelectricity & Arrhythmia Center, Washington University, St. Louis, MO 63130-4899
-
3.
Department of Bioengineering, University of California San Diego
-
Received:
01 September 2010
Accepted:
29 June 2018
Published:
01 June 2011
-
-
MSC :
Primary: 92C50; Secondary: 92C45.
-
-
Mutations of the SCN5A gene can significantly alter the function of cardiac myocyte sodium channels leading to increased risk of ventricular arrhythmia. Over the past decade, detailed Markov models of the action potential of cardiac cells have been developed. In such models, the effects of a drug can be treated as alterations in on- and off rates between open and inactivated states on one hand, and blocked states on the other hand. Our aim is to compute the rates specifying a drug in order to: (a) restore the steady-state open probability of the mutant channel to that of normal wild type channels; and (b) minimize the difference between whole cell currents in drugged mutant and wild type cells. The difference in the electrochemical state vector of the cell can be measured in a norm taking all components and their dynamical properties into account. Measured with this norm, the difference between the state of the mutant and wild-type cell was reduced by a factor of 36 after the drug was introduced and by factors of 4 over mexitiline and 25 over lidocaine. The results suggest the potential to synthesize more effective drugs based on mechanisms of action of existing compounds.
Citation: Aslak Tveito, Glenn T. Lines, Pan Li, Andrew McCulloch. Defining candidate drug characteristics for Long-QT (LQT3) syndrome[J]. Mathematical Biosciences and Engineering, 2011, 8(3): 861-873. doi: 10.3934/mbe.2011.8.861
Related Papers:
[1] |
Luca Dedè, Francesco Regazzoni, Christian Vergara, Paolo Zunino, Marco Guglielmo, Roberto Scrofani, Laura Fusini, Chiara Cogliati, Gianluca Pontone, Alfio Quarteroni .
Modeling the cardiac response to hemodynamic changes associated with COVID-19: a computational study. Mathematical Biosciences and Engineering, 2021, 18(4): 3364-3383.
doi: 10.3934/mbe.2021168
|
[2] |
Nicholas Pearce, Eun-jin Kim .
Modelling the cardiac response to a mechanical stimulation using a low-order model of the heart. Mathematical Biosciences and Engineering, 2021, 18(4): 4871-4893.
doi: 10.3934/mbe.2021248
|
[3] |
Meng Jiang, Bo Zhou, Lei Chen .
Identification of drug side effects with a path-based method. Mathematical Biosciences and Engineering, 2022, 19(6): 5754-5771.
doi: 10.3934/mbe.2022269
|
[4] |
Pedro José Gutiérrez-Diez, Jose Russo .
Design of personalized cancer treatments by use of optimal control problems: The case of chronic myeloid leukemia. Mathematical Biosciences and Engineering, 2020, 17(5): 4773-4800.
doi: 10.3934/mbe.2020261
|
[5] |
Juan Zhou, Xiong Li, Yuanting Ma, Zejiu Wu, Ziruo Xie, Yuqi Zhang, Yiming Wei .
Optimal modeling of anti-breast cancer candidate drugs screening based on multi-model ensemble learning with imbalanced data. Mathematical Biosciences and Engineering, 2023, 20(3): 5117-5134.
doi: 10.3934/mbe.2023237
|
[6] |
Urszula Ledzewicz, Shuo Wang, Heinz Schättler, Nicolas André, Marie Amélie Heng, Eddy Pasquier .
On drug resistance and metronomic chemotherapy: A mathematical modeling and optimal control approach. Mathematical Biosciences and Engineering, 2017, 14(1): 217-235.
doi: 10.3934/mbe.2017014
|
[7] |
Adam Peddle, William Lee, Tuoi Vo .
Modelling chemistry and biology after implantation of a drug-eluting stent. Part Ⅱ: Cell proliferation. Mathematical Biosciences and Engineering, 2018, 15(5): 1117-1135.
doi: 10.3934/mbe.2018050
|
[8] |
Ana Costa, Nuno Vale .
Strategies for the treatment of breast cancer: from classical drugs to mathematical models. Mathematical Biosciences and Engineering, 2021, 18(5): 6328-6385.
doi: 10.3934/mbe.2021316
|
[9] |
Urszula Ledzewicz, Heinz Schättler .
Controlling a model for bone marrow dynamics in cancer chemotherapy. Mathematical Biosciences and Engineering, 2004, 1(1): 95-110.
doi: 10.3934/mbe.2004.1.95
|
[10] |
Kaiyin Zhou, YuxingWang, Sheng Zhang, Mina Gachloo, Jin-Dong Kim, Qi Luo, Kevin Bretonnel Cohen, Jingbo Xia .
GOF/LOF knowledge inference with tensor decomposition in support of high order link discovery for gene, mutation and disease. Mathematical Biosciences and Engineering, 2019, 16(3): 1376-1391.
doi: 10.3934/mbe.2019067
|
-
Abstract
Mutations of the SCN5A gene can significantly alter the function of cardiac myocyte sodium channels leading to increased risk of ventricular arrhythmia. Over the past decade, detailed Markov models of the action potential of cardiac cells have been developed. In such models, the effects of a drug can be treated as alterations in on- and off rates between open and inactivated states on one hand, and blocked states on the other hand. Our aim is to compute the rates specifying a drug in order to: (a) restore the steady-state open probability of the mutant channel to that of normal wild type channels; and (b) minimize the difference between whole cell currents in drugged mutant and wild type cells. The difference in the electrochemical state vector of the cell can be measured in a norm taking all components and their dynamical properties into account. Measured with this norm, the difference between the state of the mutant and wild-type cell was reduced by a factor of 36 after the drug was introduced and by factors of 4 over mexitiline and 25 over lidocaine. The results suggest the potential to synthesize more effective drugs based on mechanisms of action of existing compounds.
-
-
This article has been cited by:
1.
|
Aslak Tveito, Glenn T. Lines,
2016,
Chapter 1,
978-3-319-30029-0,
1,
10.1007/978-3-319-30030-6_1
|
|
2.
|
Karoline Horgmo Jæger, Verena Charwat, Bérénice Charrez, Henrik Finsberg, Mary M. Maleckar, Samuel Wall, Kevin E. Healy, Aslak Tveito,
Improved Computational Identification of Drug Response Using Optical Measurements of Human Stem Cell Derived Cardiomyocytes in Microphysiological Systems,
2020,
10,
1663-9812,
10.3389/fphar.2019.01648
|
|
3.
|
Karoline Horgmo Jæger, Samuel Wall, Aslak Tveito, Daniel A. Beard,
Computational prediction of drug response in short QT syndrome type 1 based on measurements of compound effect in stem cell-derived cardiomyocytes,
2021,
17,
1553-7358,
e1008089,
10.1371/journal.pcbi.1008089
|
|
4.
|
Aslak Tveito, Mary M. Maleckar, Glenn T. Lines,
Computing Optimal Properties of Drugs Using Mathematical Models of Single Channel Dynamics,
2018,
6,
2544-7297,
41,
10.1515/cmb-2018-0004
|
|
-
-